Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1701259

registered interest
date	16/04/2024
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Departmental Expenditure Limits
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, by how much (a) Resource Departmental Expenditure Limits and (b) Capital Departmental Expenditure Limits will be reduced following the cancellation of the northern leg of HS2 in each affected Department; and if he will publish in which Departments these savings will be made.
tabling member constituency	Wyre and Preston North
tabling member printed	Mr Ben Wallace
uin	21946
answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>The government has committed to re-invest every penny that is saved from the cancelled phases of HS2 into alternative transport projects through Network North.</p><p>This means that every penny of the £19.8 billion committed to the Northern leg of HS2 will be reinvested in the North; every penny of the £9.6 billion committed to the Midlands leg will be reinvested in the Midlands; and the full £6.5 billion saved through our rescoped approach at Euston will be spread across every other region in the country.</p><p>Departmental Expenditure Limits in 2024-25 are published at the relevant Estimates in the usual way. Departmental budgets beyond 2024-25 will be set as part of the next Spending Review.</p> answering member constituency Sevenoaks answering member printed Laura Trott question first answered 19/04/2024 10:17:56 answering member 4780 label Biography information for Laura Trott
tabling member	1539 label Biography information for Mr Ben Wallace

1701260

registered interest
date	16/04/2024
answering body	Foreign, Commonwealth and Development Office
answering dept id	208
answering dept short name	Foreign, Commonwealth and Development Office
answering dept sort name	Foreign, Commonwealth and Development Office
hansard heading	Hong Kong: Civil Liberties
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Deputy Foreign Secretary, what discussions his Department has had with international partners on civil liberties in Hong Kong.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	21988
answer	answer is ministerial correction date of answer 24/04/2024 answer text <p>The UK continues to act as a convening power, bringing together our international partners to stand up for the people of Hong Kong, to call out violations of their rights and freedoms, and to hold China to its international obligations. That includes through the G7 and the Media Freedom Coalition. On 20 March, the UK raised Hong Kong's new national security legislation (Article 23) at the UN Human Rights Council, setting out our view that it will further erode rights and freedoms in the city.</p> answering member constituency Berwick-upon-Tweed answering member printed Anne-Marie Trevelyan question first answered 24/04/2024 13:47:51 answering member 4531 label Biography information for Anne-Marie Trevelyan
tabling member	4131 label Biography information for Jim Shannon

1701261

registered interest
date	16/04/2024
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Reserve Forces
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, how many former members of the regular Army have regular reserve call out liability as of 1 April 2024.
tabling member constituency	Wyre and Preston North
tabling member printed	Mr Ben Wallace
uin	21947
answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>As at 1 January 2024 there were 22,676 Army Regular Reservists with recall liability under Section 22 of the Reserve Forces Act (RFA) 96.</p><p> </p><p>In addition, there are approximately 55,000 ex-Regular personnel as of March 2024 subject to recall under Section 68 of the RFA 96.</p><p> </p><p>Notes/caveats:</p><p> </p><ol><li>The number of Army Regular Reservists with a recall liability can only be provided as at 1 January 2024 in line with Published National Statistics.</li><li>The Army Regular Reserve comprises ex-Regular Army personnel who retain a workforce obligation to be called up for service in times of need.</li><li>This figure includes the serving component which comprises ex-Regular personnel who have applied to return to Army service on a fixed term Reserve commitment.</li><li>The second figure comprises of personnel who have completed their military service and retain a liability to be recalled for service in the event of national danger, great emergency or an actual or suspected attack on the UK.</li><li>This figure is a single Service estimate based on management information which is not gathered for statistical purposes or subject to the same level of scrutiny as official statistics produced by Defence Statistics. The data as of March 2024 is the latest available.</li><li>The c55,000 includes ex-Regular Officers who retain a recall liability in perpetuity.</li></ol><p> </p><p> </p> answering member constituency South West Wiltshire answering member printed Dr Andrew Murrison grouped question UIN 21948 question first answered 19/04/2024 10:25:36 answering member 1466 label Biography information for Dr Andrew Murrison
tabling member	1539 label Biography information for Mr Ben Wallace

1700669

registered interest
date	15/04/2024
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	High Speed 2 Line: Compensation
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether HS2 Ltd and its agents base their offers to acquire property in connection with HS2 upon valuations fully in accordance with (1) the Royal Institution of Chartered Surveyors' Red Book, and (2) the compensation code; and, if not, what criteria they apply to property compensation valuations.
tabling member printed	Lord Berkeley
uin	HL3718
answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>HS2 Ltd makes offers to acquire properties under a variety of statutory and discretionary schemes. There is no single or universal process that applies to all acquisitions. HS2 Ltd and its agents apply the Red Book and Compensation Code where applicable, dependent on the circumstances and type of offer being made.</p><p> </p> answering member printed Lord Davies of Gower question first answered 29/04/2024 10:28:13 answering member 4499 label Biography information for Lord Davies of Gower
tabling member	3526 label Biography information for Lord Berkeley

1700670

registered interest
date	15/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ticks
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, following the publication of the UK Health Security Agency report Health Effects of Climate Change (HECC) in the UK: State of the evidence 2023 in January, what steps they are taking to inform health professionals of the heightened risk to public health of (1) Lyme disease, and (2) emerging tick-borne diseases, including tick-borne encephalitis, from an increase in the UK distribution of tick species as a result of a warming climate; and what advice are they providing to those exposed to this risk through work or leisure.
tabling member printed	The Earl of Caithness
uin	HL3728
answer	answer is ministerial correction date of answer 23/04/2024 answer text <p>The UK Health Security Agency (UKHSA) has an active programme to promote awareness of tick-borne diseases among local authorities, health professionals and the public by 2025 in line with the Third National Adaptation Programme. This includes Lyme disease and tick-borne encephalitis. UKHSA has worked to develop a toolkit for local authorities and key stakeholders to raise awareness of the potential risks created by ticks and tick-borne disease, a copy of which is attached. UKHSA also publishes Lyme disease data on Fingertips, which is an open access public health data platform which allows the public, health professionals, and local authorities to view trends, compare indicators and understand the incidence of Lyme disease in their area.</p><p>Clinicians are also engaged via teaching sessions for General Practitioners, seminars for infection specialists, and briefing notes to notify clinicians of the possibility of tick-borne diseases, with detail of compatible signs and symptoms. Disease messaging is shared through media, social, and stakeholder channels at a national and regional level, such as the #BeTickAware campaign which aims to raise awareness in the population, including those at risk of exposure through work or leisure.</p> answering member printed Lord Markham question first answered 23/04/2024 11:38:44 answering member 4948 label Biography information for Lord Markham attachment 1 file name Be_tick_aware_toolkit.pdf title Be_tick_aware_toolkit
tabling member	3310 label Biography information for The Earl of Caithness

1700671

registered interest
date	15/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Shortages
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to mitigate the current shortage of the psychotropic medication Olanzapine, Risperidone and Haloperidol following the sudden departure of two generic manufacturers from the UK market.
tabling member printed	Lord Carlile of Berriew
uin	HL3729
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>We are aware that there have been supply constraints with olanzapine 210 milligram, 300 milligram, and 405 milligram powder and solvent for prolonged release suspension for injection. We worked with manufacturers to uplift production, and the issues were resolved in February 2024. We worked with NHS England to issue national communications containing advice on how to manage patients whilst there was a disruption to supply. We are not aware of any supply issues affecting oral presentations of olanzapine, or of any supply issues with any risperidone or haloperidol products.</p> answering member printed Lord Markham grouped question UIN HL3730 question first answered 22/04/2024 15:15:21 answering member 4948 label Biography information for Lord Markham
tabling member	1138 label Biography information for Lord Carlile of Berriew

1700672

registered interest
date	15/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Olanzapine: Shortages
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the impact of the shortage of the psychotropic medication Olanzapine, and what steps they are taking to ensure that such shortages do not affect the health and safety of patients, and wider public safety.
tabling member printed	Lord Carlile of Berriew
uin	HL3730
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>We are aware that there have been supply constraints with olanzapine 210 milligram, 300 milligram, and 405 milligram powder and solvent for prolonged release suspension for injection. We worked with manufacturers to uplift production, and the issues were resolved in February 2024. We worked with NHS England to issue national communications containing advice on how to manage patients whilst there was a disruption to supply. We are not aware of any supply issues affecting oral presentations of olanzapine, or of any supply issues with any risperidone or haloperidol products.</p> answering member printed Lord Markham grouped question UIN HL3729 question first answered 22/04/2024 15:15:21 answering member 4948 label Biography information for Lord Markham
tabling member	1138 label Biography information for Lord Carlile of Berriew

1700673

registered interest
date	15/04/2024
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Climate Change: Risk Management
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether they will update statutory guidance on climate risk management, as part of their review of climate risk reporting requirements which was due to take place in the second half of 2023 or otherwise; and in particular whether any updated guidance will take account of the report of the Institute and Faculty of Actuaries and the University of Exeter Climate Scorpion – the sting is in the tail published in March.
tabling member printed	Lord Davies of Brixton
uin	HL3731
answer	answer is ministerial correction date of answer 24/04/2024 answer text <p>My Lords, we are undertaking a post-implementation review of the Occupational Pension Schemes (Climate Change Governance and Reporting) Regulations 2021. We aim to conclude the review this year.</p><p> </p><p> </p><p>We recognise that recent reports, including “Climate Scorpion-the sting is in the tail” have shown the limitations of the models currently available for scenario analysis. Therefore, we welcome work within the industry to ensure that scenario analysis models are decision useful and will look to acknowledge the issue in the review.</p><p> </p><p> </p><p>However, we do not believe that the Government should mandate which models should be used by Pension Schemes. It is important that modelling which takes into account of ESG is allowed to develop and evolve as data availability increases.</p> answering member printed Viscount Younger of Leckie question first answered 24/04/2024 16:00:52 answering member 4169 label Biography information for Viscount Younger of Leckie
tabling member	4893 label Biography information for Lord Davies of Brixton

1700674

registered interest
date	15/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tofersen: Licensing
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the negative impact on pharmaceutical research investment in the UK of the refusal by National Institute for Health and Care Excellence to approve tofersen for SOD-1 MND patients in the UK.
tabling member printed	Baroness Finlay of Llandaff
uin	HL3732
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) has not yet started its evaluation of tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations, and has therefore not published any guidance or recommendations on whether tofersen should be available for National Health Service patients. In developing its recommendations, the NICE will follow its published methods for health technology evaluation, which will include a thorough assessment of the available evidence. This takes into account all health-related costs and benefits, including health benefits not only to patients but, where relevant, to other people such as carers. The NICE’s aim is to publish its guidance on tofersen as close as possible to the date it receives its marketing authorisation.</p> answering member printed Lord Markham grouped question UIN HL3733 question first answered 22/04/2024 15:05:49 answering member 4948 label Biography information for Lord Markham
tabling member	3609 label Biography information for Baroness Finlay of Llandaff

1700675

registered interest
date	15/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tofersen
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what consideration was given to the costs of complicated grief in families of patients dying from SOD-1 MND during the evaluation process that led to the decision to decline access to tofersen for NHS patients.
tabling member printed	Baroness Finlay of Llandaff
uin	HL3733
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) has not yet started its evaluation of tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations, and has therefore not published any guidance or recommendations on whether tofersen should be available for National Health Service patients. In developing its recommendations, the NICE will follow its published methods for health technology evaluation, which will include a thorough assessment of the available evidence. This takes into account all health-related costs and benefits, including health benefits not only to patients but, where relevant, to other people such as carers. The NICE’s aim is to publish its guidance on tofersen as close as possible to the date it receives its marketing authorisation.</p> answering member printed Lord Markham grouped question UIN HL3732 question first answered 22/04/2024 15:05:49 answering member 4948 label Biography information for Lord Markham
tabling member	3609 label Biography information for Baroness Finlay of Llandaff